Description
Prior to its market debut, Gardasil appeared to offer female empowerment, touting protection against HPV and its potential for cervical cancer. Gottlieb questions the marketing pitch’s vaunted promise and asks why vaccine marketing unnecessarily gendered the vaccine’s utility, undermining Gardasil’s benefit for women and men alike. This book demonstrates why within the ten years since Gardasil’s U.S. launch its low rates of public acceptance have their origins within the early days of the vaccine dissemination. Not Slightly a Cancer Vaccine addresses the on-going expansion in U.S. healthcare of patients-as-consumers and the ever present, and on occasion insidious, health marketing of large pharma.